A novel oral budesonide formulation is highly effective for induction of remission in patients with active eosinophilic esophagitis: Results from the 6-weeks open-label treatment phase of EOS-2 trial

Alfredo J. Lucendo  1     Christoph Schlag  2     Stephan Miehlke  3     Luc Biedermann  4     Cecilio Santander Vaquero  5     Dirk Hartmann  6     Jamal Hayat     Petr Hruz     Constanza Ciriza De Los Ríos     Arjan Bredenoord     Michael Vieth     Ralph Müller     Roland Greinwald     Alex Straumann    
1 Hospital General de Tomelloso,Tomelloso,Spain
2 Technische Universität München,München,Germany
3 Coopertion of Internal Medicine Center for Digestive Diseases,Hamburg,Germany
4 USZ Zürich,Zürich,Switzerland
5 Hospital Universitario de La Princesa,Madrid,Spain
6 Sana Klinikum Lichtenberg,Berlin,G

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing